Call us now0755-8668-0658 E-mailinfo@immuclin.com

07

01

Warmly celebrate ISKCON's recognition as a "National High-tech Enterprise"!
Article Author:admin Category:Coperate News Reading:324
On December 15, 2015, the Shenzhen Municipal Science and Technology Innovation Commission officially issued the "Notice on Receiving Shenzhen's 2015 Second Batch of National High-tech Enterprises and the First Batch of National High-tech Enterprise Certificates Passing the Review. Shenzhen Yishi Kangning Biological Technology Co., Ltd. successfully passed the certification of "National High-tech Enterprise", with a validity period of 3 years.

Shenzhen Yishi Kangning Co., Ltd. was included in the list of Shenzhen high-tech enterprises in October 2014. On this basis, according to the “High-tech Enterprise” jointly issued by the Ministry of Science and Technology, the Ministry of Finance and the State Administration of Taxation in April and July 2008, Relevant regulations of the “Regulation Management Measures” (Guoke Fahuo [2008] No. 172) and the “Guidelines for the Management of High-tech Enterprise Certification” (Guoke Fahuo [2008] No. 362), as well as company declaration, expert review, and Shenzhen Science and Technology Innovation Commission With the review of the Shenzhen Municipal Finance Committee, social announcements, and the filing of the Torch Center of the Ministry of Science and Technology, the "National High-tech Enterprise" certification was finally completed. The "Administrative Measures" and "Work Guidelines" have made stricter regulations on the identification standards and approval procedures of high-tech enterprises, which greatly increased the threshold for identification of enterprises.

ISKCON National High-tech Enterprise Certificate
The successful approval of Ishikoning fully demonstrates Ishikoning's leading level in the field of anti-tumor biotherapy and the company's comprehensive strength, which has successfully reached a new level. This is a testimony of the company's leadership team's active development, and it is also a commendation for the joint efforts of all employees of the company. ISKCON will make persistent efforts to bring better products to patients.

National high-tech enterprises refer to the continuous research and development and the transformation of technological achievements within the "High-tech Fields Supported by the State" to form the core independent intellectual property rights of the enterprise, and carry out business activities on the basis of this in China (excluding Hong Kong , Australia, and Taiwan) resident enterprises registered for more than one year.

Shenzhen Yishi Kangning Biotechnology Co., Ltd. was established in 2012 and is committed to the research and development of ACTL targeted cellular immune technology. It has obtained five international patents and eight domestic patent protections, and Yishi Kangning has independent intellectual property rights. This technology is the world's first, with high safety, strong lethality, wide application range, no side effects, and reversible human resistance to monoclonal antibodies. It is an effective targeted technology and has become a tumor treatment. One of the important means of

Keyword:
Share: